Antilymphocyte-antibody prophylaxis: review of the adult experience in heart transplantation.
Taylor
D O
DO
University of Utah Health Sciences Center, Veterans Affairs Medical Center, Salt Lake City, USA.
Kfoury
A G
AG
Pisani
B
B
Hammond
E H
EH
Renlund
D G
DG
D000328:Adult; D000818:Animals; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000517:prevention & control; D016027:Heart Transplantation / Q000276:immunology* / Q000401:mortality; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016853:Muromonab-CD3 / Q000627:therapeutic use*; D011183:Postoperative Complications / Q000453:epidemiology; D015996:Survival Rate
D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D016853:Muromonab-CD3